{"id":79069,"date":"2026-03-31T12:06:58","date_gmt":"2026-03-31T12:06:58","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/"},"modified":"2026-03-31T12:06:58","modified_gmt":"2026-03-31T12:06:58","slug":"nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/","title":{"rendered":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting"},"content":{"rendered":"<div>\n<p>Fort Lee, NJ, March  31, 2026  (GLOBE NEWSWIRE) &#8212; Nuvectis Pharma, Inc. (NASDAQ: NVCT) (&#8220;Nuvectis&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP900 at the upcoming 2026 American Association for Cancer Research Meeting (2026 AACR), taking place from April 17th to April 22nd in San Diego, CA.<\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><b>Abstract Title<\/b><\/td>\n<td style=\"border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><b>Poster Presentation Details<\/b><\/td>\n<\/tr>\n<tr>\n<td style=\"border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; \">NXP900, a Phase 1b, first-in-class YES1\/SRC inhibitor demonstrates potent synergy with KRAS inhibitors in KRASi sensitive and resistant NSCLC models<\/td>\n<td style=\"border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; \"><b>Session Title<\/b><br \/>Combination Targeted Therapy<\/p>\n<p><b>Session Date \/ Time<\/b><br \/>April 21st, 2:00 PM \u2013 5:00 PM PT<\/td>\n<\/tr>\n<tr>\n<td style=\"border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; \">Resistance to the SFK inhibitor NXP900 in cholangiocarcinoma is characterized by IL13RA2-AKT signaling and can be overcome by combination therapy<\/td>\n<td style=\"border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; \"><b>Session Title<\/b><br \/>Novel Strategies to Reverse Drug Resistance<\/p>\n<p><b>Session Date \/ Time<br \/><\/b>April 22nd, 9:00 AM \u2013 12:00 PM PT<\/td>\n<\/tr>\n<tr>\n<td style=\"border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; \">Targeting myeloid-derived suppressor cells (MDSCs) to restore antitumor immunity in non-small cell lung cancer (NSCLC) via SRC family kinase Inhibition with NXP900<\/td>\n<td style=\"border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; \"><b>Session Title<\/b><br \/>Tyrosine Kinase, Phosphatase, and Other Inhibitors<\/p>\n<p><b>Session Date \/ Time<\/b><br \/>April 21st, 2:00 PM \u2013 5:00 PM PT<\/td>\n<\/tr>\n<\/table>\n<p><b>About Nuvectis Pharma, Inc.<\/b><\/p>\n<p>Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. The Company is developing NXP900, a clinical-stage drug candidate. NXP900 is an oral small molecule inhibitor of the SRC Family of Kinases (SFK), including SRC and YES1. Its unique mechanism of action enables inhibition of both the catalytic and scaffolding functions of the SRC kinase, providing comprehensive shutdown of the signaling pathway. NXP900 has completed a Phase 1a dose escalation study, a drug-drug interaction study in healthy volunteers and the Phase 1b program has been initiated.<\/p>\n<p>For more information on Nuvectis, please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FEAUzprRNO2nrJCeS0pJDkNRSaD69Y6MlbRqye-HbBlL8OrEpg2u8zzQ0hV4R2Z1_OtXKmTmnGR9uaOA-SYIfurtRm50QHR9vYUfGwYHW2I=\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/nuvectis.com\/<\/a>.<\/p>\n<p><b>Company Contact<\/b><\/p>\n<p>Ron Bentsur<br \/>Chairman, Chief Executive Officer and President <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nuKNPBAJzB_x36NncT1slOsRFD8ZZXww5arx4h8GsFSetGZ0_1M5Wz7G9OspUOBjHihRj5vz8czhlzfxONCwlOODjjnH_nQ1rZUv1UmOEps=\" rel=\"nofollow\" target=\"_blank\" title=\"rbentsur@nuvectis.com\">rbentsur@nuvectis.com<\/a><\/p>\n<p><b>Media Relations Contact<\/b><\/p>\n<p>Kevin Gardner<br \/>LifeSci Advisors <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dtHxG-DApaqV3-c2_1_Ca62YCYyaAucoEdW-JHQ7ygryG1VlvP6694_VczwMuosoUNG6AMiYdmLLO4MHS9H-slnD3XgKvWqXD1GGDraoCMiAGI62dOZdwci_2ZPsyDJw\" rel=\"nofollow\" target=\"_blank\" title=\"kgardner@lifesciadvisors.com\">kgardner@lifesciadvisors.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGQ3Y2Y3YTktYjg0My00NDJiLTg4MzQtZmMxYTdhMzFmZTdhLTUwMDA4MjgxNy0yMDI2LTAzLTMxLWVu\/tiny\/Nuvectis-Pharma-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) &#8212; Nuvectis Pharma, Inc. (NASDAQ: NVCT) (&#8220;Nuvectis&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP900 at the upcoming 2026 American Association for [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-79069","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting\" \/>\n<meta property=\"og:description\" content=\"Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) &#8212; Nuvectis Pharma, Inc. (NASDAQ: NVCT) (&#8220;Nuvectis&#8221; or the &#8220;Company&#8221;), a cl\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-31T12:06:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/media\/ZGQ3Y2Y3YTktYjg0My00NDJiLTg4MzQtZmMxYTdhMzFmZTdhLTUwMDA4MjgxNy0yMDI2LTAzLTMxLWVu\/tiny\/Nuvectis-Pharma-Inc-.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting\",\"datePublished\":\"2026-03-31T12:06:58+00:00\",\"dateModified\":\"2026-03-31T12:06:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\"},\"wordCount\":339,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\",\"name\":\"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-03-31T12:06:58+00:00\",\"dateModified\":\"2026-03-31T12:06:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting","og_description":"Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) &#8212; Nuvectis Pharma, Inc. (NASDAQ: NVCT) (&#8220;Nuvectis&#8221; or the &#8220;Company&#8221;), a cl","og_url":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-03-31T12:06:58+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/media\/ZGQ3Y2Y3YTktYjg0My00NDJiLTg4MzQtZmMxYTdhMzFmZTdhLTUwMDA4MjgxNy0yMDI2LTAzLTMxLWVu\/tiny\/Nuvectis-Pharma-Inc-.png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting","datePublished":"2026-03-31T12:06:58+00:00","dateModified":"2026-03-31T12:06:58+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/"},"wordCount":339,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/","url":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/","name":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-03-31T12:06:58+00:00","dateModified":"2026-03-31T12:06:58+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-the-2026-american-association-for-cancer-research-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/79069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=79069"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/79069\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=79069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=79069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=79069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}